Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Novotech Holdings (NVT HK)
Watchlist
13
Analysis
Health Care
•
China
Largest biotech specialist contract research organization (CRO) in Asia
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Novotech Holdings
•
08 Sep 2021 18:48
Novotech Health IPO: Valuation First-Look
Novotech is pre-marketing an HKEx IPO to raise $0.5-1.0 billion. In this note, we present our forecasts and take the first look at Novotech's...
Arun George
Follow
268 Views
Share
bullish
•
Broncus
•
08 Sep 2021 03:10
Broncus Holdings IPO: Say No to Lung Diseases
Broncus' core products have a competitive edge over its competition due to their unique features, helping it to capture more of the growing...
Shifara Samsudeen, ACMA, CGMA
Follow
318 Views
Share
bullish
•
Novotech Holdings
•
07 Sep 2021 00:13
Novotech Health IPO: Structural Tailwinds in the APAC Biotech CRO Market Offers LT Growth
Novotech is well positioned to benefit from the tailwinds in the APAC clinical CRO market where it generates a majority of its revenue from China,...
Shifara Samsudeen, ACMA, CGMA
Follow
300 Views
Share
bullish
•
Novotech Holdings
•
06 Sep 2021 22:26
Novotech Health IPO: A Solid Start to 2021
We examine the PHIP which discloses the 1Q21 results along with additional disclosures and recent developments. Overall, we continue to maintain...
Arun George
Follow
307 Views
Share
bullish
•
Novotech Holdings
•
04 Sep 2021 22:37
Novotech Health IPO Initiation: On-Demand Science
Novotech is set to pre-market an HKEx IPO to raise up to $1.5 bn. Novotech’s fundamentals are solid and the IPO is worth a look for investors...
Arun George
Follow
278 Views
Share
Previous
1
2
3
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.31.2
x